SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-14-069039
Filing Date
2014-11-17
Accepted
2014-11-17 09:20:50
Documents
3
Period of Report
2014-11-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v394443_8-k.htm 8-K 18240
2 EXHIBIT 99.1 v394443_ex99-1.htm EX-99.1 70353
3 GRAPHIC image_001.jpg GRAPHIC 5415
  Complete submission text file 0001144204-14-069039.txt   97556
Mailing Address 721 ROUTE 202/206, SUITE 130 BRIDGEWATER NJ 08807
Business Address 721 ROUTE 202/206, SUITE 130 BRIDGEWATER NJ 08807 908-864-4444
Sevion Therapeutics, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-31326 | Film No.: 141226556
SIC: 8731 Services-Commercial Physical & Biological Research